{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:32:19Z","timestamp":1787502739661,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2208085MH248"],"award-info":[{"award-number":["2208085MH248"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbamcr.2025.120094","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:04:45Z","timestamp":1764921885000},"page":"120094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Activation of YBX1 and JAK2\/STAT3 pathways by RIOK1 increases lenvatinib resistance in hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"1873","author":[{"given":"Ruirui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120094_bb0010","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bbamcr.2025.120094_bb0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","article-title":"Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications","volume":"31","author":"Safri","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/JHC.S411806","article-title":"Application and resistance mechanisms of lenvatinib in patients with advanced hepatocellular carcinoma","volume":"10","author":"Tao","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"8","key":"10.1016\/j.bbamcr.2025.120094_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104069","article-title":"New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma","volume":"29","author":"Fan","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120094_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189100","article-title":"A role for RIO kinases in the crosshair of cancer research and therapy","volume":"1879","author":"Ghandadi","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41420-023-01704-7","article-title":"The RioK1 network determines p53 activity at multiple levels","volume":"9","author":"Damizia","year":"2023","journal-title":"Cell Death Discov."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.120094_bb0055","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ajpath.2023.05.013","article-title":"The oncogenic protein kinase\/ATPase RIOK1 is up-regulated via the c-myc\/E2F transcription factor axis in prostate cancer","volume":"193","author":"Handle","year":"2023","journal-title":"Am. J. Pathol."},{"issue":"25","key":"10.1016\/j.bbamcr.2025.120094_bb0060","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1038\/s41388-022-02352-4","article-title":"RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120094_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020717","article-title":"Y-box binding protein 1: unraveling the multifaceted role in cancer development and therapeutic potential","volume":"25","author":"Dinh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0075","article-title":"LncRNA USP2-AS1 promotes hepatocellular carcinoma growth by enhancing YBX1-mediated HIF1alpha protein translation under hypoxia","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.120094_bb0085","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.7150\/ijbs.96031","article-title":"Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1\/2 axis in hepatocellular carcinoma","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120094_bb0090","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/15548627.2022.2117893","article-title":"Genome-scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma","volume":"19","author":"Pan","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2025.120094_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175876","article-title":"Eriocalyxin B ameliorated Crohn\u2019s disease-like colitis by restricting M1 macrophage polarization through JAK2\/STAT1 signalling","volume":"954","author":"Cheng","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2018.06.009","article-title":"Osteopontin attenuates inflammation via JAK2\/STAT1 pathway in hyperglycemic rats after intracerebral hemorrhage","volume":"138","author":"Gong","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0105","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1038\/s41598-021-84837-y","article-title":"A gene module identification algorithm and its applications to identify gene modules and key genes of hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114402","article-title":"XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"160","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101965","article-title":"YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: a comprehensive investigation through bioinformatics analysis and in vitro study","volume":"45","author":"Li","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216495","article-title":"IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma","volume":"581","author":"Ru","year":"2024","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.bbamcr.2025.120094_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512224","article-title":"Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment","volume":"24","author":"Foglia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbamcr.2025.120094_bb0130","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.bbamcr.2025.120094_bb0135","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int."},{"issue":"Pt 3","key":"10.1016\/j.bbamcr.2025.120094_bb0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120094_bb0145","first-page":"1067","article-title":"Elevated expression of RIOK1 is correlated with breast cancer hormone receptor status and promotes cancer progression","volume":"52","author":"Huang","year":"2020","journal-title":"Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120094_bb0150","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.7150\/jca.64668","article-title":"RIOK1 is associated with non-small cell lung cancer clinical characters and contributes to cancer progression","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbamcr.2025.120094_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.978236","article-title":"DKK3\u2019s protective role in prostate cancer is partly due to the modulation of immune-related pathways","volume":"14","author":"Shareef","year":"2023","journal-title":"Front. Immunol."},{"issue":"47","key":"10.1016\/j.bbamcr.2025.120094_bb0160","article-title":"Targeting the SPC25\/RIOK1\/MYH9 axis to overcome tumor stemness and platinum resistance in epithelial ovarian cancer","volume":"11","author":"Jiang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","article-title":"Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120094_bb0170","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/cas.14006","article-title":"Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer","volume":"110","author":"Kuwano","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbamcr.2025.120094_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110073","article-title":"A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance","volume":"85","author":"Alkrekshi","year":"2021","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120094_bb0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12967-023-04267-4","article-title":"RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3","volume":"21","author":"Shi","year":"2023","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.bbamcr.2025.120094_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813764","article-title":"Exploring the JAK\/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120094_bb0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41419-022-04806-9","article-title":"Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2\/STAT3\/NOX1-mediated ROS production","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120094_bb0195","first-page":"2579","article-title":"Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells","volume":"53","author":"Chua","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"180","key":"10.1016\/j.bbamcr.2025.120094_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.24976\/Discov.Med.202436180.19","article-title":"Curcumol enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells","volume":"36","author":"Wu","year":"2024","journal-title":"Discov. Med."},{"issue":"8","key":"10.1016\/j.bbamcr.2025.120094_bb1000","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M116.740258","article-title":"Novel serine 176 phosphorylation of YBX1 activates NF-\u03baB in colon cancer","volume":"292","author":"Martin","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:59:39Z","timestamp":1768402779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0167488925001995"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120094","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of YBX1 and JAK2\/STAT3 pathways by RIOK1 increases lenvatinib resistance in hepatocellular carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120094"}}